Storing & Dosing Information | Adbry®

Approved for adults and children ages 12+ years. Click here for different pediatric dosing information.

Keeping up with your treatment routine

Once you learn how to inject Adbry® (tralokinumab-ldrm), it’s important to keep up with your treatment routine based on your healthcare professional’s direction.

Click here for more information on proper Adbry® storage and dosing information.

Not an actual patient.
Individual results may vary.

Storing Adbry

Adbry should be stored in the refrigerator between 36°F and 46°F (or 2°C and 8°C)

Don’t freeze the syringes or use syringes that have been previously frozen.

Like all medicines, Adbry should be kept out of the reach of children.

Getting Adbry

Adbry is a injection that requires special shipping and handling by a . This means that your medicine will be shipped to you, rather than having to pick it up in person.

are similar to local pharmacies in a number of ways. The major difference between the two is that a manages medicines that require special handling (e.g., require refrigeration).

Once you’ve been prescribed Adbry, your will process your prescription, confirm your shipping address over the phone, and then deliver the medicine to your home by mail.

The Adbry® Advocate™ Program is here to help you through the process, if you are eligible. Call 844-MY-ADBRY (844-692-3279) for help coordinating your Adbry shipment.

Image of Adbry® (tralokinumab-ldrm) carton

Not actual size.

Ask a Case Manager about resources available to you

Icon of Sharps Container

Sharps Container

Safely dispose of your used Adbry prefilled syringes with a complimentary . After about 5 to 6 months, mail your full container back and we’ll send you a new one.

Welcome Pack

The Adbry Welcome Pack includes an educational brochure, a and Reference Guide, and information on savings and support programs for eligible patients.

Travel Cold Case

Use this case to help carry up to 2 Adbry cartons (4 syringes) safely while you travel.

Stay on track with the Adbry Digital Companion

We partnered with Medisafe^®, a top-rated medication management app, to create the Adbry Digital Companion. This free-to-use app delivers medication reminders in real time, educational content, and additional support right to your smart device.

Once your healthcare professional prescribes Adbry, download the Medisafe app from your app store and add Adbry to your digital medicine cabinet.

Adbry Medisafe Apple App Store

Adbry Medisafe Google Play

App Store is a service mark of Apple Inc., registered in the U.S. and other countries. Google Play and the Google Play logo are trademarks of Google LLC. Medisafe is a registered trademark of Medisafe Project LTD.

Keep learning about Adbry:

The Adbry® Advocate™ Program

Sign up for support

Guide to starting Adbry

Download the guide

Frequently asked questions

Get Adbry answers

INDICATION AND IMPORTANT SAFETY INFORMATION

Read more Collapse

What is ADBRY?

ADBRY® (tralokinumab-ldrm) injection is a prescription medicine used to treat people 12 years of age and older with moderate-to-severe atopic dermatitis (eczema) that is not well controlled with prescription therapies used on the skin (topical), or who cannot use topical therapies. ADBRY can be used with or without topical corticosteroids.
It is not known if ADBRY is safe and effective in children under 12 years of age.

Do not use ADBRY if you are allergic to tralokinumab or to any of its ingredients.

What should I discuss with my healthcare provider before starting ADBRY?

Tell your healthcare provider about all your medical conditions, including if you:

have eye problems.
have a parasitic (helminth) infection.
are scheduled to receive any vaccinations. You should not receive a “live vaccine” if you are treated with ADBRY.
are pregnant or plan to become pregnant. It is not known whether ADBRY will harm your unborn baby. There is a pregnancy exposure registry for women who use ADBRY during pregnancy. The purpose of this registry is to collect information about the health of you and your baby. You or your healthcare provider can get information and enroll you in this registry by calling 1-877-311-8972 or visiting https://mothertobaby.org/ongoing-study/adbry-tralokinumab/.
are breastfeeding or plan to breastfeed. It is not known whether ADBRY passes into your breast milk and if it can harm your baby.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I use ADBRY?

See the detailed “Instructions for Use” that comes with ADBRY for information on how to prepare and inject ADBRY and how to properly store and throw away (dispose of) used ADBRY prefilled syringes.
Use ADBRY exactly as prescribed by your healthcare provider.
Your healthcare provider will tell you how much ADBRY to inject and when to inject it.
ADBRY comes as a single-dose (150 mg) prefilled syringe with needle guard.
ADBRY is given as an injection under the skin (subcutaneous injection).
If your healthcare provider decides that you or a caregiver can give the injection of ADBRY, you or your caregiver should receive training on the right way to prepare and inject ADBRY. Do not try to inject ADBRY until you have been shown the right way by your healthcare provider.
If you miss a dose, inject the missed dose as soon as possible, then continue with your next dose at your regular scheduled time.
If you inject too much ADBRY than prescribed, call your healthcare provider or call Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away.

Your healthcare provider may prescribe other medicines to use with ADBRY. Use the other prescribed medicines exactly as your healthcare provider tells you to.

What are the possible side effects of ADBRY?

ADBRY can cause serious side effects including:

Allergic reactions (hypersensitivity), including a severe reaction known as anaphylaxis. Stop using ADBRY and tell your healthcare provider or get emergency help right away if you get any of the following symptoms:
- breathing problems
- itching
- skin rash
- swelling of the face, mouth, and tongue
- fainting, dizziness, feeling lightheaded (low blood pressure)
- hives

Eye problems. Tell your healthcare provider if you have any worsening eye problems, including eye pain or changes in vision.

The most common side effects of ADBRY include:

Upper respiratory tract infections
Eye and eyelid inflammation, including redness, swelling, and itching
Injection site reactions
High count of a certain white blood cell (eosinophilia)

These are not all of the possible side effects of ADBRY. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see full Prescribing Information, including Patient Information and Instructions for Use.